2025-05-04
Alarming Cancer Surge Post-Vaccine Rollout: 76.2% Rise in Mortality and 171.4% Increase in Postpartum Cases
A Freedom of Information response from United Lincolnshire Hospitals NHS Trust (FOI 884/24, 28 April 2025) uncovered a disturbing rise in advanced cancer cases and deaths post-COVID-19 vaccine rollout. From 2017-2020, 2,760 patients were diagnosed with Stage 3 or 4 cancers (any type), with 811 (29.4%) dying within 12 months. From 2021-2024, diagnoses rose to 3,170, with 1,429 (45.0%) deaths—a 76.2% increase in mortality. More alarmingly, colorectal cancer among postpartum women under 45 surged 171.4%, with 19 cases (2021-2024) compared to 7 (2017-2020), and mortality rose from 0% to 5.3%-21.1% (<5 deaths within 12 months), potentially underreported due to the 12-month limit. This crisis, exemplified by Sharon Plummer’s and Rachel Partin’s rapid Stage 4 colorectal cancers post-mRNA vaccination, suggests vaccine contaminants like SV40, plasmid ORI, and spike protein may drive aggressive cancers via P53 suppression (Speicher, 2023; Dalgleish, 2024). Rachel’s biopsy confirmed ORI+/spike+ in her tumor; Sharon’s tests are pending. A follow-up FOI (30 April 2025) seeks vaccination status and genetic data to probe vaccine links, amplified by postpartum immune shifts (Czech Oncology Journal, 2023). The MHRA’s dismissal of risks (8 April 2025) ignores excess DNA evidence (188-509x over limits) and Slovakia’s vaccine halt (23 April 2025). We demand mRNA vaccine suspension for pregnant women, batch testing, and biopsy analysis.
2025-05-04
Aggressive Cancers Linked to mRNA Vaccine Contaminants: Sharon and Rachel’s Stories
Sharon Plummer and Rachel Partin, both postpartum and under 40, died from rapid Stage 4 colorectal cancers post-mRNA vaccination, raising alarms about vaccine contaminants. Sharon (Doses May/July 2021) was diagnosed September 2023 and died 31 days later; Rachel (Doses 2021-2023) was diagnosed February 2023, 3 weeks postpartum, and died March 2024. Rachel’s biopsy (INMODIA, April 2025) confirmed plasmid ORI and spike protein in her tumour, suggesting DNA integration and P53 suppression (Speicher, 2023; Dalgleish, 2024). Sharon’s pending tests may show similar SV40/ORI/spike presence. Experts (McKernan, Fukushima, Soon-Shiong) link contaminants to cancer via immune disruption, amplified by postpartum immune shifts (Czech Oncology Journal, 2023). Speicher’s EU-cited data (188-509x excess DNA) and Slovakia’s vaccine halt (April 2025) contradict the MHRA’s “no cancer risk” claim (April 2025). These cases support the FOI’s 171.4% postpartum cancer surge (2021-2024) and demand vaccine suspension, batch testing, and biopsy analysis.
2025-05-04
Sharon Plummer’s Cancer Start Date: July 2021, Scientifically Confirmed
A rigorous report definitively places the onset of Sharon Plummer’s colorectal cancer (Stage 4, diagnosed September 20, 2023, died October 21, 2023) in July 2021, based on comprehensive medical and genetic data. Sourced from medical records (June 2022–October 2023, United Lincolnshire Hospitals NHS Trust) and genetic testing (Nottingham University Hospitals), the analysis identifies two tumor-specific APC mutations driving her sporadic 6 cm sigmoid tumor with liver metastases. The timeline anchors on June 2023 inflammation (ALP 163 U/L, Hb 99 g/L), December 2022 pain, and May 2023 bleeding, applying the adenoma-carcinoma sequence (Journal of Clinical Oncology, 2018). Back-calculating 1.5–2 years from T2–T3 (June 2023) and 1–1.5 years from T0–T1 (December 2022), July 2021 emerges as the precise start. This aligns with Sharon’s COVID 19 vaccinations (May/July 2021) and the 171.4% postpartum cancer surge (FOI 884/24). The report’s unimpeachable methodology demands investigation into potential triggers.